2,221
Participants
Start Date
April 30, 2007
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
CDB-2914
Single dose
Levonorgestrel
Single dose
Planned Parenthood Hollywood, Los Angeles
Planned Parenthood Santa Monica, Santa Monica
Planned Parenthood of the Rocky Mountains, Boulder
Planned Parenthood of the Rocky Mountains, Denver
Planned Parenthood of the Rocky Mountains, Littleton
Planned Parenthood of Greater Miami, Lake Worth
Planned Parenthood of Greater Miami, Miami
Planned Parenthood of Greater Miami, North Miami
Planned Parenthood of Greater Miami, Stuart
Planned Parenthood of Greater Miami, West Palm Beach
Planned Parenthood of Northeast Ohio Akron Health Center, Akron
Planned Parenthood of Northeast Ohio Bedford Health Center, Bedford
Planned Parenthood of Northeast Ohio East Cleveland Health Center, Cleveland
Planned Parenthood of Northeast Ohio Old Brooklyn Health Center, Cleveland
Planned Parenthood of Northeast Ohio Kent Health Center, Kent
Planned Parenthood of Northeast Ohio Rocky River Health Center, Rocky River
Planned Parenthood of Texas Capitol Region, Austin
Fannin Health Center, Houston
Planned Parenthood of Houston and Southeast Texas Research Department, Houston
Planned Parenthood Association of Utah, Ogden
Planned Parenthood Association of Utah, Orem
Planned Parenthood Association of Utah, Salt Lake City
Planned Parenthood Association of Utah, West Valley City
Well Woman Centre, Dublin
NHS Grampian Sexual and Reproductive Health, Aberdeen
Brook Family Planning Clinic, Belfast
NHS Lothian Family Planning Service, Edinburgh
NHS Greater Glasgow & Clyde Family Planning Service, Glasgow
Liverpool PCT Family Planning Services, Liverpool
London Sexual and Reproductive Health, London
Manchester Primary Care Trust, Manchester
Nottingham Contraception & Sexual Health Service, Nottingham
Oxfordshire PCT Community Health, Oxford
Lead Sponsor
HRA Pharma
INDUSTRY